1. Generic & Brand Names
Generic: Loperamide HCl
Brands: Imodium® (global), Diamode®, Loperacap®
Combinations: Imodium® Plus (with simethicone)
Formulations:
Capsules/Tablets (2mg)
Liquid (1mg/5mL, 1mg/7.5mL)
Chewable tablets
OTC Availability: Yes (restricted in some countries)
2. Drug Class & Mechanism
Class: Opioid Receptor Agonist (peripherally acting)
Mechanism:
Binds μ-opioid receptors in the intestinal wall → ↓ peristalsis, ↑ transit time
↑ Anal sphincter tone → reduces urgency/frequency
No CNS effects at standard doses (doesn't cross BBB)
3. FDA-Approved Uses
| Indication | Details |
|---|---|
| Acute Diarrhea | Adults & children ≥6 years |
| Chronic Diarrhea | IBS-D, IBD maintenance (off-label) |
| Traveler's Diarrhea | First-line with antibiotics |
4. Dosing Regimens
| Group | Initial Dose | Maintenance | Max Daily |
|---|---|---|---|
| Adults | 4 mg (2 tabs) | 2 mg after each loose stool | 8 mg/day* |
| Children 9-11 yrs | 2 mg | 1 mg after each loose stool | 6 mg/day |
| Children 6-8 yrs | 2 mg | 1 mg after each loose stool | 4 mg/day |
* FDA Limit: 8 mg/24h OTC; 16 mg/24h Rx (with restrictions)
Never use in children <6 years (respiratory depression risk)
5. Black Box Warning (FDA 2019)
Cardiac Risks:
QT prolongation → Torsades de Pointes
Fatal arrhythmias reported with doses >16 mg/day
Abuse Potential:
Used to achieve opioid "high" (requires 50-100+ mg)
Causes euphoria when combined with CYP inhibitors
6. Side Effects
| Common (≥5%) | Serious (Require Discontinuation) |
|---|---|
| Constipation | Toxic Megacolon (IBD patients) |
| Dizziness | Paralytic Ileus |
| Nausea | QT Prolongation → Cardiac Arrest |
| Abdominal pain | Hypersensitivity Reactions |
7. Absolute Contraindications
Bloody diarrhea (may worsen C. diff/invasive pathogens)
Fever >101.3°F (38.5°C)
Ulcerative colitis/C. diff infection
Concomitant QT-prolonging drugs (amiodarone, macrolides)
8. Critical Drug Interactions
| Medication | Risk |
|---|---|
| CYP3A4 Inhibitors | ↑ Loperamide levels 3-4x → ↑ toxicity (e.g., ritonavir, grapefruit) |
| CYP2C8 Inhibitors | Gemfibrozil → ↑ levels 2-3x |
| Opioids | ↑ CNS depression |
9. Abuse-Deterrent Formulations
Imodium® Advanced (EU): Added naloxone (blocks opioid receptors if crushed/injected)
US Restrictions:
Blister packaging (max 12 capsules per pack)
Behind-counter sales in some states
10. When to Seek Medical Help
Stop loperamide and consult MD immediately if:
Diarrhea >48 hours
Blood/mucus in stool
Fever or severe abdominal pain
Dizziness/fainting (cardiac warning)
Clinical Alternatives
| Scenario | Safer Alternatives |
|---|---|
| Mild Diarrhea | Bismuth subsalicylate (Pepto-Bismol®) |
| IBS-D | Eluxadoline, Rifaximin |
| C. diff | Vancomycin, Fidaxomicin |
Patient Counseling
"Never exceed maximum dose – 8 mg/day OTC."
"Discontinue if no improvement in 24h – may indicate infection."
"Avoid with grapefruit juice – increases toxicity risk."
"Seek ER for:
Fast/irregular heartbeat
Severe constipation/abdominal swelling
Bloody stools"
⚠️ Red Flag: Combining loperamide with ketoconazole or ritonavir has caused fatal arrhythmias at therapeutic doses.
Prescribing Status: OTC with purchase limits; Rx for chronic conditions (max 16 mg/day with ECG monitoring).
Global Status: Restricted to Rx-only in France, Japan, and parts of the Middle East.
Sources: FDA Drug Safety Communication (2019), EMA Review (2018), Clin Gastroenterol Hepatol.
Comments
Post a Comment